Global Point of Care Diagnostics/Testing Market Overview:
Global Point of Care Diagnostics/Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Point of Care Diagnostics/Testing Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Point of Care Diagnostics/Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Point of Care Diagnostics/Testing Market:
The Point of Care Diagnostics/Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Point of Care Diagnostics/Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Point of Care Diagnostics/Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Point of Care Diagnostics/Testing market has been segmented into:
Glucose Monitoring
Cardiometabolic Monitoring
Infectious Disease Testing
Coagulation Monitoring
Pregnancy & Fertility Testing
Hematology Testing
Cancer/Tumor Marker Testing
Urinalysis Testing
Cholesterol
Drugs-of-Abuse Testing
By Application, Point of Care Diagnostics/Testing market has been segmented into:
Direct ARDS
Indirect ARDS
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Point of Care Diagnostics/Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Point of Care Diagnostics/Testing market.
Top Key Players Covered in Point of Care Diagnostics/Testing market are:
Air Liquide
ResMed
Draeger
Hamilton Medical AG
Getinge
Evonik Industries
GE Healthcare
Smiths Medical
Vyaire Medical
Medtronic
Philips Healthcare
Linde Healthcare
Teleflex
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Point of Care Diagnostics/Testing Market Type
4.1 Point of Care Diagnostics/Testing Market Snapshot and Growth Engine
4.2 Point of Care Diagnostics/Testing Market Overview
4.3 Glucose Monitoring
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Glucose Monitoring: Geographic Segmentation Analysis
4.4 Cardiometabolic Monitoring
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Cardiometabolic Monitoring: Geographic Segmentation Analysis
4.5 Infectious Disease Testing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Infectious Disease Testing: Geographic Segmentation Analysis
4.6 Coagulation Monitoring
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Coagulation Monitoring: Geographic Segmentation Analysis
4.7 Pregnancy & Fertility Testing
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Pregnancy & Fertility Testing: Geographic Segmentation Analysis
4.8 Hematology Testing
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.8.3 Hematology Testing: Geographic Segmentation Analysis
4.9 Cancer/Tumor Marker Testing
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.9.3 Cancer/Tumor Marker Testing: Geographic Segmentation Analysis
4.10 Urinalysis Testing
4.10.1 Introduction and Market Overview
4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.10.3 Urinalysis Testing: Geographic Segmentation Analysis
4.11 Cholesterol
4.11.1 Introduction and Market Overview
4.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.11.3 Cholesterol: Geographic Segmentation Analysis
4.12 Drugs-of-Abuse Testing
4.12.1 Introduction and Market Overview
4.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.12.3 Drugs-of-Abuse Testing: Geographic Segmentation Analysis
Chapter 5: Point of Care Diagnostics/Testing Market Application
5.1 Point of Care Diagnostics/Testing Market Snapshot and Growth Engine
5.2 Point of Care Diagnostics/Testing Market Overview
5.3 Direct ARDS
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Direct ARDS: Geographic Segmentation Analysis
5.4 Indirect ARDS
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Indirect ARDS: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Point of Care Diagnostics/Testing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 AIR LIQUIDE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 RESMED
6.4 DRAEGER
6.5 HAMILTON MEDICAL AG
6.6 GETINGE
6.7 EVONIK INDUSTRIES
6.8 GE HEALTHCARE
6.9 SMITHS MEDICAL
6.10 VYAIRE MEDICAL
6.11 MEDTRONIC
6.12 PHILIPS HEALTHCARE
6.13 LINDE HEALTHCARE
6.14 TELEFLEX
Chapter 7: Global Point of Care Diagnostics/Testing Market By Region
7.1 Overview
7.2. North America Point of Care Diagnostics/Testing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Glucose Monitoring
7.2.2.2 Cardiometabolic Monitoring
7.2.2.3 Infectious Disease Testing
7.2.2.4 Coagulation Monitoring
7.2.2.5 Pregnancy & Fertility Testing
7.2.2.6 Hematology Testing
7.2.2.7 Cancer/Tumor Marker Testing
7.2.2.8 Urinalysis Testing
7.2.2.9 Cholesterol
7.2.2.10 Drugs-of-Abuse Testing
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Direct ARDS
7.2.3.2 Indirect ARDS
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Point of Care Diagnostics/Testing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Glucose Monitoring
7.3.2.2 Cardiometabolic Monitoring
7.3.2.3 Infectious Disease Testing
7.3.2.4 Coagulation Monitoring
7.3.2.5 Pregnancy & Fertility Testing
7.3.2.6 Hematology Testing
7.3.2.7 Cancer/Tumor Marker Testing
7.3.2.8 Urinalysis Testing
7.3.2.9 Cholesterol
7.3.2.10 Drugs-of-Abuse Testing
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Direct ARDS
7.3.3.2 Indirect ARDS
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Point of Care Diagnostics/Testing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Glucose Monitoring
7.4.2.2 Cardiometabolic Monitoring
7.4.2.3 Infectious Disease Testing
7.4.2.4 Coagulation Monitoring
7.4.2.5 Pregnancy & Fertility Testing
7.4.2.6 Hematology Testing
7.4.2.7 Cancer/Tumor Marker Testing
7.4.2.8 Urinalysis Testing
7.4.2.9 Cholesterol
7.4.2.10 Drugs-of-Abuse Testing
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Direct ARDS
7.4.3.2 Indirect ARDS
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Point of Care Diagnostics/Testing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Glucose Monitoring
7.5.2.2 Cardiometabolic Monitoring
7.5.2.3 Infectious Disease Testing
7.5.2.4 Coagulation Monitoring
7.5.2.5 Pregnancy & Fertility Testing
7.5.2.6 Hematology Testing
7.5.2.7 Cancer/Tumor Marker Testing
7.5.2.8 Urinalysis Testing
7.5.2.9 Cholesterol
7.5.2.10 Drugs-of-Abuse Testing
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Direct ARDS
7.5.3.2 Indirect ARDS
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Point of Care Diagnostics/Testing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Glucose Monitoring
7.6.2.2 Cardiometabolic Monitoring
7.6.2.3 Infectious Disease Testing
7.6.2.4 Coagulation Monitoring
7.6.2.5 Pregnancy & Fertility Testing
7.6.2.6 Hematology Testing
7.6.2.7 Cancer/Tumor Marker Testing
7.6.2.8 Urinalysis Testing
7.6.2.9 Cholesterol
7.6.2.10 Drugs-of-Abuse Testing
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Direct ARDS
7.6.3.2 Indirect ARDS
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Point of Care Diagnostics/Testing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Glucose Monitoring
7.7.2.2 Cardiometabolic Monitoring
7.7.2.3 Infectious Disease Testing
7.7.2.4 Coagulation Monitoring
7.7.2.5 Pregnancy & Fertility Testing
7.7.2.6 Hematology Testing
7.7.2.7 Cancer/Tumor Marker Testing
7.7.2.8 Urinalysis Testing
7.7.2.9 Cholesterol
7.7.2.10 Drugs-of-Abuse Testing
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Direct ARDS
7.7.3.2 Indirect ARDS
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Point of Care Diagnostics/Testing Scope:
|
Report Data
|
Point of Care Diagnostics/Testing Market
|
|
Point of Care Diagnostics/Testing Market Size in 2025
|
USD XX million
|
|
Point of Care Diagnostics/Testing CAGR 2025 - 2032
|
XX%
|
|
Point of Care Diagnostics/Testing Base Year
|
2024
|
|
Point of Care Diagnostics/Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Air Liquide, ResMed, Draeger, Hamilton Medical AG, Getinge, Evonik Industries, GE Healthcare, Smiths Medical, Vyaire Medical, Medtronic, Philips Healthcare, Linde Healthcare, Teleflex.
|
|
Key Segments
|
By Type
Glucose Monitoring
Cardiometabolic Monitoring
Infectious Disease Testing
Coagulation Monitoring
Pregnancy & Fertility Testing
Hematology Testing
Cancer/Tumor Marker Testing
Urinalysis Testing
Cholesterol
Drugs-of-Abuse Testing
By Applications
Direct ARDS
Indirect ARDS
|
